The KOLLO Group in Los Angeles underwent an inspection by the Food and Drug Administration (FDA) on March 26, according to data posted on the FDA’s website.
The inspection concluded that The KOLLO Group needed to address operational controls related to foodborne biological hazards. No corrective action was required in other evaluated areas.
The FDA routinely inspects facilities throughout the country to ensure that workplaces and their products comply with laws and regulations intended to safeguard public health. The results from these inspections are made publicly available.
According to its website, the FDA is a federal agency primarily in charge of regulating the production and distribution of human and animal pharmaceuticals, biological products, medical devices, and tobacco goods to ensure their safety and quality.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
